Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Elastomeric Infusion Pumps Market size was valued at USD 734.54 Million in 2024 and is poised to grow from USD 788.16 Million in 2025 to USD 1384.88 Million by 2033, growing at a CAGR of 7.3% during the forecast period (2026–2033).

    Key competitors in the highly competitive elastomeric infusion pump market are Terumo Corporation, Smiths Medical, and Baxter International. These businesses focus on product diversification, technology upgrades, and expanding distribution networks to have an edge in the race. Companies are also investing in alliances and teamwork to raise their market share in developing countries and to cater to the ever-increasing demand for home healthcare solutions. 'Baxter (US) ', 'Fresenius Kabi AG (Germany) ', 'B. Braun SE (Germany) ', 'Ambu A/S (Denmark) ', 'NIPRO (Japan) ', 'Terumo Corporation (Japan) ', 'AVNS (US) ', 'Vygon Group (France) ', 'Smiths Group plc (UK) ', 'ICU Medical, Inc. (US) ', 'Pajunk GmbH (Germany) ', 'Woo Young Medical Co., Ltd. (South Korea) ', 'Sapphire Medical (Israel) ', 'Ace Medical Co., Ltd. (South Korea) ', 'Eitan Medical (Israel) ', 'Zyno Medical (US) ', 'Epic Medical (Singapore) ', 'Nipro Corporation (Japan) ', 'Daiken Medical Co., Ltd. (Japan) ', 'Coopdech (Japan) ', 'Westmed, Inc. (US) ', 'Flowonix Medical Inc. (US)'

    Hybridizing Digital Health Solutions: There is a growing usage of elastomeric infusion pumps hyphenated with digital health solutions, encompassing such hybrid solutions as telemedicine platforms and smartphone apps. These hybrid solutions enhance the accuracy and efficiency of therapy through real-time monitoring and adjustment of infusions rates. Furthermore, remote monitoring increases patient safety by allowing medical professionals to monitor the infusion process and take rapid action if needed. Due to this trend, elastomeric pumps are becoming increasingly popular and increasingly applied in home care settings. 

    Factors driving the expansion of the elastomeric infusion pumps market in North America include an increased need for infusion pumps, especially elastomeric infusion pumps, which would arise from increased incidence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases. There is further a growing demand for more portable and easier-to-use infusion systems as home healthcare services are increasing. Technological advancements in elastomeric pumps for the improvement in the comfort and accuracy of drug administration are expanding the market. Reimbursement policies in favor and a strong healthcare infrastructure are bolstering the growth for this market. In addition, with the aging population in North America, there is an increased demand for infusion pumps for managing chronic diseases. 

    Feedback From Our Clients

    Global Elastomeric Infusion Pumps Market

    Report ID: SQMIG35A2679

    $5,300
    BUY NOW